Stocks in news today

’s subsidiary -- Biocon Biologics has received U.S. Food and Drug Administration (FDA) approval for Bosaya (denosumab-kyqq) 60 mg/mL injection for subcutaneous use in a single dose prefilled syringe (PFS), and Aukelso (denosumab-kyqq) 120 mg/1.7 mL (70 mg/mL) injection for subcutaneous use in a single-dose vial, biosimilars of Prolia and Xgeva respectively. In addition, the U.S. FDA granted provisional interchangeability designation for both BOSAYA and AUKELSO. (CSL) has signed a contract with Oil and Natural Gas Corporation (ONGC) for Dry dock/ Major Lay-up repairs of one of its Jack Up Rig. The estimated contract value is around Rs 200 crore and the estimated duration for the project is around 12 months. has launched the TVS King Deluxe Plus CNG 3 Wheeler in Tanzania. The launch announcement was conducted at Dar Es Salaam Gymkhana Sports Club in the presence of dealers, retail finance partners and fleet owners. This new CNG 3 Wheeler is designed to address the dynamic requirements of urban and semi-urban mobility. The TVS King Deluxe Plus CNG 3 Wheeler combines robust design, performance, and reliability with cutting-edge technology. With this launch, TVS Motor Company underscores its commitment to providing Tanzanian customers with affordable, durable, and fuel-efficient mobility solutions.